WEBULL
News
DRTS
5.10
+0.99%
0.05
Weekly Report: what happened at DRTS last week (1215-1219)?
Weekly Report · 5d ago
Alpha Tau Expands Alpha DaRT Into Recurrent Prostate Cancer: What Investors Should Watch
TipRanks · 12/18 16:32
Alpha Tau Medical to Present Corporate Update at J.P. Morgan Healthcare Conference
Reuters · 12/18 14:01
Weekly Report: what happened at DRTS last week (1208-1212)?
Weekly Report · 12/15 09:32
Alpha Tau Medical’s Innovative Prostate Cancer Therapy: Study Completion Update
TipRanks · 12/14 16:32
Alpha Tau Medical’s Innovative Cancer Treatment Study Update: A Potential Game-Changer
TipRanks · 12/14 16:31
Alpha Tau Medical Is Maintained at Buy by Citigroup
Dow Jones · 12/10 19:25
Alpha Tau Medical Price Target Cut to $7.00/Share From $8.00 by Citigroup
Dow Jones · 12/10 19:25
Citigroup Maintains Buy on Alpha Tau Medical, Lowers Price Target to $7
Benzinga · 12/10 19:15
Promising Clinical Developments and Innovative Technology Drive Buy Rating for Alpha Tau Medical Ltd
TipRanks · 12/10 11:35
Optimistic Growth Prospects and Strategic Developments Drive Buy Rating for Alpha Tau Medical Ltd
TipRanks · 12/10 10:07
Alpha Tau Treats First U.S. Brain Cancer Patient With Alpha DaRT; Shares Surge On Breakthrough
NASDAQ · 12/10 08:30
Why Did Alpha Tau Medical (DRTS) Shares Jump Over 25% In After-Hours Trading?
Benzinga · 12/10 06:41
After-Hours Rally: Stoke Therapeutics, Alpha Tau Medical, Compass Pathways Lead Biotech Movers
NASDAQ · 12/10 04:35
Alpha Tau Treats First U.S. Patient with Alpha DaRT for Glioblastoma
TipRanks · 12/09 14:30
Alpha Tau announces first patient treated in study using Alpha DaRT tech
TipRanks · 12/09 14:11
ALPHA TAU MEDICAL LTD - TREATS FIRST PATIENT IN GLIOBLASTOMA STUDY
Reuters · 12/09 14:04
Alpha Tau Medical Treats First Glioblastoma Patient with Alpha DaRT in U.S. Trial
Reuters · 12/09 14:00
Weekly Report: what happened at DRTS last week (1201-1205)?
Weekly Report · 12/08 09:32
Alpha Tau Medical to Present Pancreatic Cancer Research at 2026 ASCO Symposium
TipRanks · 12/04 14:27
More
Webull provides a variety of real-time DRTS stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTS
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.